Abnormal liver panel in acute kawasaki disease (Q34985732)

5 August 2017

Abnormal liver panel in acute kawasaki disease (English)

1 reference

5 August 2017

1 reference

Mohammed Eladawy

1

1 reference

5 August 2017

Samuel R Dominguez

series ordinal

2

1 reference

5 August 2017

Marsha S Anderson

series ordinal

3

1 reference

5 August 2017

Mary P Glodé

series ordinal

4

1 reference

5 August 2017

1 February 2011

1 reference

Pediatric Infectious Disease Journal

5 August 2017

1 reference

5 August 2017

30

1 reference

5 August 2017

2

1 reference

5 August 2017

141-144

1 reference

Risk factors for failure of initial intravenous immunoglobulin treatment in Kawasaki disease

5 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3096016

Resistance to intravenous immunoglobulin in children with Kawasaki disease

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3096016

Acute cholestasis: atypical onset of Kawasaki disease

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3096016

Management and outcome of intravenous gammaglobulin-resistant Kawasaki disease.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3096016

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3096016

Hepatocellular damage from non-steroidal anti-inflammatory drugs

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3096016

Acute surgical abdomen as presenting manifestation of Kawasaki disease

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3096016

Antioxidants may mitigate the deterioration of coronary arteritis in patients with Kawasaki disease unresponsive to high-dose intravenous gamma-globulin

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3096016

Causes and mechanisms of hypoalbuminaemia

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3096016

The meaning of hypoalbuminaemia in clinical practice

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3096016

Acute febrile cholestasis as an inaugural manifestation of Kawasaki's disease

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3096016

The role of albumin in critical illness

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3096016

Elevated gamma-glutamyltransferase concentrations in patients with acute Kawasaki disease

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3096016

Salicylate hepatitis: a complication of the treatment of Kawasaki's disease

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3096016

Clinical and epidemiologic characteristics of patients referred for evaluation of possible Kawasaki disease. United States Multicenter Kawasaki Disease Study Group

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3096016

Pathology of Kawasaki disease: II. Distribution and incidence of the vascular lesions

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3096016

Aging of cardiac myocytes in culture: oxidative stress, lipofuscin accumulation, and mitochondrial turnover

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3096016

Serum alanine aminotransferase concentrations in patients with Kawasaki disease

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3096016

Gallbladder hydrops: complication of Kawasaki disease

26 October 2018

1 reference

12 December 2020

Intrahepatic cholangitis associated with mucocutaneous lymph node syndrome

1 reference

12 December 2020

Hepatomegaly and splenomegaly in Kawasaki disease

1 reference

12 December 2020

Intrahepatic bile duct damage in children with Kawasaki disease

1 reference

12 December 2020

Serum concentrations of total bile acids in patients with acute Kawasaki syndrome

1 reference

12 December 2020

Intravenous gamma-globulin treatment and retreatment in Kawasaki disease. US/Canadian Kawasaki Syndrome Study Group

1 reference

12 December 2020

Prediction of non-responsiveness to standard high-dose gamma-globulin therapy in patients with acute Kawasaki disease before starting initial treatment

1 reference

12 December 2020

Atypical relapsing course of Kawasaki disease with hemorrhagic serous effusions and hepatic dysfunction

1 reference

12 December 2020

10.1097/INF.0B013E3181F6FE2A

Identifiers

DOI

1 reference

5 August 2017

1 reference

5 August 2017

1 reference